Alesse 21

GPTKB entity

Statements (47)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:clinical_trial efficacy studies
safety studies
gptkbp:contains gptkb:ethinyl_estradiol
gptkb:levonorgestrel
gptkbp:contraindication liver disease
certain cancers
history of blood clots
smoking over age 35
gptkbp:dosage_form gptkb:tablet
0.02 mg ethinyl estradiol
0.1 mg levonorgestrel
gptkbp:duration 28 days
gptkbp:effective_date gptkb:1999
gptkbp:form generic version
brand name version
https://www.w3.org/2000/01/rdf-schema#label Alesse 21
gptkbp:ingredients gptkb:ethinyl_estradiol
gptkb:levonorgestrel
gptkbp:interacts_with gptkb:St._John's_Wort
antibiotics
anticonvulsants
HIV medications
gptkbp:is_used_for contraception
gptkbp:manager oral
gptkbp:manufacturer gptkb:physicist
gptkbp:marketed_as gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
gptkbp:packaging blister pack
gptkbp:regulatory_compliance FDA approved
TGA approved
Health Canada approved
gptkbp:requires prescription only
gptkbp:scholarships not for use during pregnancy
missed dose instructions
take at the same time daily
consult doctor for side effects
gptkbp:side_effect headache
nausea
weight gain
breast tenderness
mood changes
gptkbp:storage room temperature
gptkbp:bfsParent gptkb:Alesse
gptkbp:bfsLayer 6